INTRODUCTION
Lipoic acid (LA) or 1,2-dithiolane-3-pentaenoic acid is a naturally occurring compound that contains two thiol groups with diverse beneficial effects on health. The biological effects of LA were primarily associated with its antioxidant properties. In fact, LA is able to directly scavenge reactive oxygen species (ROS) and regenerate endogenous antioxidants such as glutathione, and vitamins E and C (1, 2) . Moreover, several studies have described potential beneficial effects of LA on obesity and associated commorbidities such as insulin resistance, type 2 diabetes or fatty liver diseases. Thus, in rodents LA has been shown to cause profound weight loss by reducing food intake and enhancing energy expenditure (3) as well as by inducing a reduction on intestinal sugar absorption (4) . More recently, two clinical trials in humans reported that LA caused significant reductions of body weight, body mass index (BMI), blood pressure and abdominal circumference in obese subjects (5, 6) . LA also improved insulin sensitivity and plasma lipid profile possibly through amelioration of oxidative stress and chronic inflammatory status in obese patients with impaired glucose tolerance (7) . Previous studies provided strong evidences that LA is able to deeply affect adipose tissue development and function by the inhibition of adipogenesis (8), the regulation of the secretion of several adipokines such as leptin (9) and apelin (10) and also by the promotion of mitochondrial biogenesis (11) .
In this context, previous studies suggested that LA seems to stimulate the lipolytic response in an in vitro model of broiler chicken adipocytes (12) . However, the molecular mechanisms that mediate these effects remain unclear. Lipolysis is a complex process highly regulated, which involves the co-ordinately participation of several lipases and lipid droplet (LD) proteins (13) . Thus, the lipolytic process occurs through the consecutive action of three lipases: adipose triglyceride lipase (ATGL/desnutrin), hormone-sensitive lipase (HSL) and monoacylglycerol lipase (MAGL) (14) . ATGL exhibits high substrate specificity for triacyl by guest, on www.jlr.org Downloaded from 4 glycerol (TAG) (15) . Lipase activity of ATGL largely depends on its coactivation by CGI-58, while G0S2 acts as an inhibitor of ATGL activity and ATGL-mediated lipolysis (16).
Recently it has been shown that ATGL is phosphorylated by AMPK at Ser 406 , increasing TAG hydrolase activity (17) .
The activity of HSL is well known to be regulated post-transcriptionally by reversible phosphorylation. In murine adipocytes PKA phosphorylates HSL at several serine residues (563, 659, and 660) resulting in increased translocation of HSL to the lipid droplet surface and increased lipolytic activity (18) . Furthermore, AMP-activated protein kinase (AMPK)
phosphorylates HSL at Ser 565 , which prevents phosphorylation induced by PKA (19, 20) .
Activation of phosphodiesterase 3B (PDE3B) via the Akt-mediated phosphorylation of Ser 273 attenuates PKA activity and thereby HSL activation and lipolysis (21, 22) . In addition to the PKA-mediated phosphorylation, HSL may be also phosphorylated by other kinases such as ERK1/2, which activates HSL by phosphorylation on Ser 600 (23) . It has been also suggested that JNK could play a role in the regulation of lipolysis based on the fact that silencing of Jnk1 and Jnk2 accelerates basal lipolysis in mouse adipocytes (24) .
Protein trafficking and specific protein-protein interactions at the surface of lipid droplets are also key factors in the regulation of lipolysis. Perilipin A is a lipid droplet scaffold protein that plays a central role in orchestrating interactions among lipolytic effector proteins (25) .
Under basal conditions, perilipin restricts the access of cytosolic lipases to LD, thereby maintaining a low rate of basal lipolysis. However, the phosphorylation of perilipin by PKA results in perilipin conformational changes that expose LD stores and facilitates the translocation of phosphorylated HSL to the LD, thereby increasing the lipolytic process (26).
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AdPLA null mice exhibited reduced adipose tissue prostaglandin E 2 (PGE 2 ) production, and augmented HSL-phosphorylation leading to increased lipolysis, supporting that AdPLA is a major regulator of adipocyte lipolysis by regulating PGE 2 abundance (28) .
Previous studies have demonstrated the ability of LA to modulate ERK, JNK and Akt signaling pathways (8, 9, 29), as well as AMPK activity (30, 31) in different cell types.
Moreover, LA stimulates cAMP production in purified human NK cells (32) and modulates the production of PGE 2 in osteoblasts (33) .
Based on these previous findings, we hypothesized that LA could be a key regulator of lipolysis in mammals through modulation of lipases and lipid droplet proteins activities.
Therefore, the aim of this study was to characterize the lipolytic action of LA in cultured adipocytes and to elucidate the molecular mechanisms and signaling pathways involved.
MATERIAL AND METHODS

Cell culture and differentiation of 3T3-L1 cells
Murine 3T3-L1 cells (American Type Culture Collection, Rockville, MD, USA) were cultured in Dulbecco´s modified Eagle´s medium (DMEM) containing 25 mM glucose, 10%
calf bovine serum (Invitrogen, CA, USA) and 1% penicillin and streptomycin (Gibco, Invitrogen Corporation, CA, USA) and were maintained in an incubator set up to 37 ºC and 5% of CO 2 . At confluence pre-adipocytes were induced to differentiate into adipocytes by culturing them for 48 h in DMEM containing 10% fetal bovine serum (FBS) (Invitrogen), antibiotics and supplemented with dexamethasone (1 mM; Sigma, St. Louis, MO, USA), isobutylmethylxantine (0.5 mM; Sigma) and insulin (10 mg/mL; Sigma). Then, cells were cultured with 10% FBS and insulin for 48 h. After that, media was replaced with 10% FBS in DMEM and antibiotics, but without insulin and this media was changed every 2 days up to day 8 post confluence, when cells were completely differentiated to adipocytes (34, 35) . mmol/l AICAR).
Lipolysis measurement
Lipolysis was evaluated by measuring the amount of glycerol and free fatty acids released to the media. Glycerol was determined after 1 to 24 h of LA treatment using an autoanalyser following the manufacturer instructions (Cobas-Mira, Roche Diagnostics, Basel, Swiss). Free fatty acids were quantified after 3 h of LA treatment by using the Lipolysis Assay KIT for The reaction conditions were followed according to manufacturer's instructions.
Amplification and detection of specific products were performed using the ABI PRISM 7900HT Fast System Sequence Detection System (Applied Biosystems).
All mRNA levels were normalized by the housekeeping gene β-Actin obtained from Applied
Biosystems. Samples were analyzed in duplicate. Ct values (the cycle where the emitted fluorescence signal is significantly above background levels and is inversely proportional to the initial template copy number) were generated by the ABI software. Finally, the relative expression level of each gene was calculated as 2 -ΔΔCt (36) .
Western blot analysis
Western blot analyses were performed in 8 days post-differentiation adipocytes. Cells were incubated in serum-free DMEM overnight and then with or without the appropriate treatment. quantified using a GS-800 calibrated densitometer (Bio Rad Laboratories).
Fatty acid oxidation determination
Fatty acid oxidation to acid-soluble metabolites (ASM) was measured with radiolabeled 14 Cpalmitate (Perkin Elmer, Boston, MA) in mature 3T3-L1 adipocytes as previously described (37) . ASM were extracted by addition of 1 ml cold 1 M HClO 4 (Panreac, Barcelona, Spain).
After centrifugation (10 min, 1800 g), radioactivity in the supernatant was measured by scintillation counting by using a Wallac 1409 liquid scintillation counter (EG&G Company, Turku, Finland). Protein content in parallel cultures of vehicle-and LA-treated cells was analyzed using a BCA method.
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ELISA assays
Prostaglandin E 2 (PGE 2 ) concentration in the media was determined after 24 h of LA (250 µM) treatment by using a PGE 2 Enzyme Immunoassay kit (Arbor assays, Ann Arbor, MI, USA). The amount of intracellular cAMP was quantified after 1 and 24 h of LA (250 µM) treatment by using the cAMP Direct EIA kit (Arbor Assays).
Data analysis
Data are expressed as mean ± standard errors (SE 
RESULTS
Effects of LA on lipolysis in 3T3-L1 adipocytes
A dose-dependent significant increase in the amount of glycerol released into the media was observed in those adipocytes treated with LA (250-500 µM, P<0.01 and P<0.001) for 24 h (Fig. 1A) . Moreover, the lipolytic effect of LA was time-dependent. Thus, the significant increase in glycerol release was observed after 1 h of treatment (P<0.05) and it became more prominent after 3 and 6 h of treatment (250-500 µM, (P<0.001) (Fig. 1B) . Furthermore, LA also induced a concentration-dependent increase in the amount of free fatty acids released after 3 h treatment (100-500 µM, P<0.001) (Fig. 1C) . We also tested the effects of LA on isoproterenol-induced lipolysis and the data revealed that LA did not have any additional 
Signaling pathways involved in the lipolytic actions of LA
In order to evaluate the ability of LA to modify some signaling pathways involved in the regulation of lipolysis, the phosphorylation levels of JNK, ERK1/2, AMPK and PI3K/AKT were analyzed both after a short (30 min-1h) and long-term treatment (24 h).
No effects were observed in JNK Thr (Fig. 2E) .
Effects of LA treatment on HSL, ATGL, Perilipin, CGI-58 and G0S2 levels
In contrast to the LA lipolytic actions, a significant (P<0.05) decrease on total protein content of the two main lipases ATGL and HSL was observed in LA-treated (250 µM for 24 h) adipocytes (Fig. 3A) . Accordingly, gene expression levels of both ATGL and HSL were also significantly downregulated (P<0.05) by LA treatment for 24 h (Fig. 3B) . Perilipin mRNA levels were also reduced in LA-treated adipocytes while no changes in perilipin protein content were observed ( Fig. 3A and 3B ).
The inhibitory actions of LA treatment on ATGL gene expression were not observed in presence of the JNK inhibitor SP600125 and ERK1/2 inhibitor PD98059 (P<0.05) (Fig. 3C) .
Similarly, the inhibition of the ERK1/2 signaling pathway was able to reverse the downregulation of HSL and perilipin gene expression observed after LA treatment (P<0.05) ( Fig.   3D and E). Fig. IV ).
These data suggest that LA stimulates lipolysis by increasing PKA activity. Perilipin phosphorylation is also PKA-dependent. Using a perilipin-specific antibody and a phospho-PKA-motif-specific substrate antibody, we found that LA treatment induced a marked increase (P<0.01) in PKA-mediated perilipin phosphorylation (Fig. 4C) . In fact, the LAinduced phosphorylation of HSL at Ser 563 and Ser 660 as well as of perilipin was dramatically blunted in the presence of the PKA inhibitor H89. We also found that AMPK activation disrupted the LA-induced phosphorylation of HSL at both Ser 563 and Ser 660 ( Fig. 4A and 4B ), without modifying the p-PKA substrate/perilipin ratio (Fig. 4C) . Interestingly, the inhibition of the JNK pathway induced a significant increase in the phosphorylation of HSL at Ser 660 , both in the absence and presence of LA, and in PKA-mediated perilipin phosphorylation ( Fig.   4B and 4C) . Morover, the ERK1/2 inhibitor PD98059 prevented the LA-induced phosphorylation of HSL at Ser 563 without modifying LA-effects on Ser 660 and p-PKA substrate/perilipin ratio. All these data suggest that LA stimulates lipolysis mainly through the PKA-mediated phosporylation of perilipin and HSL. However, LA treatment during 1 h did not significantly modify the protein levels of ATGL. Neither CGI-58 nor G0S2, the activator and inhibitor of ATGL activity respectively, were significantly altered after 1 or 24 h of LA treatment ( Fig. 5A and B respectively).
Effects of LA on AdPLA levels, and on PGE 2 and cAMP production
AdPLA has been described as the major phospholipase A2 in adipose tissue with a key role in the regulation of lipolysis through the modulation of PGE 2 levels. As shown in We next aimed to evaluate the effects of LA on the major AdPLA product, PGE 2 , which binds the Gi-coupled receptor EP3, and down-regulates lipolysis by inhibiting cAMP production. Our data showed that the amount of PGE 2 released to the media was significantly reduced in LA-treated adipocytes at 24 h of treatment (P<0.05) (Fig. 6B ) and also at shorter (4 and 8 h) periods of treatment (data not shown). In parallel, a significant increase in cAMP levels was found in LA-treated adipocytes for 1 and 24 h (Fig. 6C) . Moreover, the lipolytic effect of LA was partially reversed by co-treatment with PGE 2 , an effect that was not observed in the presence of the EP3-receptor antagonist L798106 (Fig. 6D ).
DISCUSSION
Our current data demonstrate the lipolytic action of LA in cultured adipocytes in a concentration and time-dependent manner. It is important to note that the doses able to induce lipolysis were similar to those that inhibited adipogenesis in 3T3-L1 preadipocytes (8) and no toxicity was observed. Previous studies in broiler chickens also support the lipolytic action of LA both in vitro and in vivo models (12, 38) . However, the mechanisms of action remain uncertain.
In the present study we tested if the lipolytic effects of LA were shared by other compounds with antioxidant properties. Our data revealed that resveratrol and BHA, but not Vitamin C or NAC were able to stimulate lipolysis, suggesting that the lipolytic actions seem to be independent of the antioxidant capacities.
Moreover, our data showed that despite the stimulatory effects of LA on lipolysis, both HSL and ATGL gene expression and protein levels were inhibited after 24 h of LA treatment, together with a decrease in perilipin mRNA levels. These effects of LA on HSL, ATGL and perilipin were reversed by the presence of the ERK1/2 inhibitor PD98059 in the media. A ATGL plays a governing role in both basal and adrenergically stimulated TAG breakdown in adipocytes (14) . However, our data suggest that ATGL activation is not importantly involved in the lipolytic action of LA as concluded from the findings that no significant changes were observed either on the levels of the ATGL co-activator protein called CGI-58 or the inhibitory protein G0S2 (16, 48).
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PI3K/AKT is a major player of insulin action and its activation increases PDE3B activity, and hydrolysis of cAMP leading to a net dephosphorylation of HSL and inhibition of lipolysis (49) . In our experimental cell model, LA inhibits AKT phosphorylation both at 30 min and 24 h of treatment, and both the PI3K/AKT inhibitor LY294002 and the PDE3B
antagonist Cilostamide potentiated the stimulatory effects of LA on basal lipolysis.
Therefore, the present results suggest that the lipolytic effects of LA could be mediated by decreasing AKT activation, which might increase cAMP, and lipolysis mediated by HSL and perilipin activation. However, our data evidenced that ERK1/2 phosphorylation is not affected by LA after 24 h of treatment and that pretreatment with PD98059 was not able to reverse the lipolytic action of LA, arguing against the involvement of this pathway.
AMPK has been also involved in the regulation of lipolysis (51, 52) . Thus, it has been reported that phosphorylation of HSL at Ser 565 by AMPK prevents activation by PKA, inhibiting lipolysis (19, 53, 54) . Moreover, the negative regulation of AMPK activity by PKA has been shown to be important for converting a lipolytic signal into an effective lipolytic response (55) . However, it has been recently reported that ATGL is phosphorylated/activated by AMPK to increase lipolysis (17) . Thus, the effects described for AMPK activators on Recently it has been described and functionally characterized a new adipocyte phospholipase A2 called AdPLA (27 suggested an activation of lipolysis may be a promising therapeutic target for the treatment of obesity (13, 61) . In this context, we and others have demonstrated that dietary supplementation with LA reduces weight loss and fat mass without increasing circulating FFA and improves insulin resistance both in rodents (10, 62, 63) and humans (7), and as previously suggested, this could be associated to LA-induced fatty acid oxidation. In this context, our experimental data support the notion about the ability of LA to promote fatty acid oxidation in 3T3-L1 adipocytes ( Supplementary Fig. V) . A recent study have also evidenced that LA subsequently increased AMPK and ACC phosphorylation, leading to increased palmitate β-oxidation in myotubes (64) . Moreover, studies of our group also have shown that LA supplementation prevents the downregulation of genes involved in mitochondrial and peroxisomal β-oxidation in liver of high fat-induced obese rats (65).
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In summary, the present data demonstrate the ability of LA to stimulate lipolysis in 3T3-L1 adipocytes and suggest that these lipolytic actions of LA are mainly mediated by the phosphorylation of HSL through cAMP-mediated activation of PKA probably through the inhibition of AdPLA and PGE 2 . 
FIGURE LEGENDS
